Trupanion (NASDAQ:TRUP) Posts Earnings Results, Misses Expectations By $0.02 EPS

Trupanion (NASDAQ:TRUP) posted its quarterly earnings results on Wednesday. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02), Zacks reports. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%.

Trupanion Trading Down 2.4 %

Shares of Trupanion stock opened at $47.51 on Thursday. Trupanion has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. The company has a fifty day moving average of $48.54 and a 200 day moving average of $47.98.

Insider Activity

In other Trupanion news, CFO Fawwad Qureshi sold 622 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total transaction of $32,723.42. Following the transaction, the chief financial officer now owns 9,867 shares in the company, valued at $519,102.87. The trade was a 5.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Emily Dreyer sold 3,100 shares of the company’s stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $54.85, for a total transaction of $170,035.00. Following the completion of the transaction, the senior vice president now owns 24,708 shares in the company, valued at $1,355,233.80. This represents a 11.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 14,681 shares of company stock worth $785,194 over the last ninety days. Corporate insiders own 5.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Northland Securities increased their price objective on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus lifted their price target on Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Finally, Piper Sandler raised shares of Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 price objective on the stock in a research note on Thursday, January 23rd. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $45.33.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.